Please try another search
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polarizer devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.
Name | Age | Since | Title |
---|---|---|---|
Bastiaan Driehuys | 54 | 2017 | Founder, Chief Scientific Officer & Director |
Bill Blair | - | 2023 | Non-Executive Director |
Frank M. Schulkes | 62 | 2022 | Non-Executive Director |
Cyrille Yann-Nicolas Petit | 54 | 2020 | Non-Executive Director |
Marcella K. Ruddy | - | 2022 | Non-Executive Director |
Daniel Myron Brague | 56 | 2022 | Independent Non-Executive Director |
Juergen Laucht | 69 | 2017 | Non-Executive Director |
Kenneth Paul West | 67 | 2017 | Chairman of the Board |
Charles Fremont Osborne | 58 | 2019 | CFO & Director |
Christopher Richard Von Jako | 54 | 2023 | CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review